Company Filing History:
Years Active: 2013
Title: **Mahabalarao Sampath Kumar Halmuthur: A Promising Innovator in Anticancer Research**
Introduction
Mahabalarao Sampath Kumar Halmuthur is an accomplished inventor based in Jammu Tawi, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel anticancer agents. With a keen focus on innovation, he has successfully obtained a patent that showcases his expertise and dedication to advancing cancer treatment options.
Latest Patents
Halmuthur holds a patent for "Spiro derivatives of parthenin as novel anticancer agents." This groundbreaking invention involves the synthesis of spiro derivatives through dipolar cycloaddition involving various dipoles such as benzonitrile oxides and azides, reacting with the exocyclic double bond of C ring (α-methylene-γ-butyrolactone). His research reports the anticancer activity of these compounds against different cancer cell lines, with IC50 values ranging from 4.3 µM to 93 µM. He also describes a mechanistic correlation of their anticancer activity, highlighting the role of the α,β-unsaturated ketonic moiety in maintaining significant cytotoxicity.
Career Highlights
Mahabalarao Sampath Kumar Halmuthur is affiliated with the Council of Scientific & Industrial Research, where he continues his vital research in anticancer drug development. His work exemplifies a commitment to addressing one of the most pressing public health challenges worldwide.
Collaborations
Throughout his career, Halmuthur has collaborated with notable colleagues such as Ajit Kumar Saxena and Subhash Chandra Taneja. Their collective efforts have enhanced the scope and impact of their research endeavors, fostering an environment of innovation and collaboration.
Conclusion
Mahabalarao Sampath Kumar Halmuthur's contributions to the development of novel anticancer agents position him as an influential figure in scientific innovation. His patent serves as a testament to his skills as an inventor, and his ongoing research holds the promise of improving cancer therapies for patients around the world.